GlassScriptPhysician profile
Mary B Beasley
NPI 1306067186
$49,899.64
in general payments reported to CMS, 2019-2025
7 companies · $2,875 in 2025
The $2,875 reported for 2025 was more than what 92% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,930 · 2020: $2,406 · 2021: $3,328 · 2022: $19K · 2023: $10K · 2024: $3,095 · 2025: $2,875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $2,550 · Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,169.00 |
| Travel and Lodging | $2,549.66 |
| Food and Beverage | $294.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $27,060.33 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $6,462.70 | 2019 | |
| Genzyme Corporation | $6,226.32 | 2023 | |
| Astrazeneca Uk Limited | $5,142.50 | 2021-2022 | |
| Eli Lilly and Company | $3,113.26 | 2019-2020 | |
| Janssen Global Services, LLC | $1,760.00 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $134.53 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Beasley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.